Received Jun 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
she had caught COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (she had caught COVID-19) in an elderly female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Moderna Covid-19 vaccine. Past adverse reactions to the above products included No adverse effect with Moderna Covid-19 vaccine. On 19-Dec-2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced COVID-19 (she had caught COVID-19). At the time of the report, COVID-19 (she had caught COVID-19) outcome was unknown. No concomitant medication was reported. The patient had all the Moderna shots, and at the time of reporting, she was due for another one. She went to four pharmacies, but nobody had the Moderna COVID-19 vaccine. She even went to the facilities listed on website (which state they had the Moderna COVID-19 vaccine), but nobody had it. She was off schedule because she had caught COVID-19, which resulted in her being recommended to wait for 6 months. She had all her Moderna COVID-19 vaccine (5 or 6 shots), the last one before she caught infected with COVID-19. She took her mask off to go to the dentist and then the dermatologist. One week after, she got COVID. The facility where she got her latest Modena COVID-19 vaccine currently did not have the vaccine, as they said they can't get it. The pharmacy only had Pfizer, but she didn't want to switch if she could get Moderna. She and her husband searched for the vaccine in several pharmacies without any result and believe they will not purchase the vaccine just for her. It was unknown if the patient experienced any additional symptoms or events. Reporter causality was not reported. No treatment medication was reported. Reporter did not allow further contact